{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:50:23Z","timestamp":1791316223897,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"DOI":"10.1007\/s10620-026-10262-8","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:06:11Z","timestamp":1791313571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suppression of TRIM33 and SMAD4 Indicates a Possible Tumor-Suppressive Role in Esophageal Squamous Cell Carcinoma"],"prefix":"10.1007","author":[{"given":"Arun","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nimisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Apurva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinki","family":"Bera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niket","family":"Harsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ejaj","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyakanti","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-7204","authenticated-orcid":false,"given":"Sundeep Singh","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"10262_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet 2024;286\u2013287:18\u201324. https:\/\/doi.org\/10.1016\/j.cancergen.2024.06.002.","journal-title":"Cancer Genet"},{"key":"10262_CR2","unstructured":"Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M. Global Cancer Observatory: Cancer Today (version 1.1) n.d."},{"key":"10262_CR3","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1016\/j.apsb.2021.03.008","volume":"11","author":"S He","year":"2021","unstructured":"He S, Xu J, Liu X, Zhen Y. Advances and challenges in the treatment of esophageal cancer. Acta Pharm Sin B 2021;11:3379\u20133392. https:\/\/doi.org\/10.1016\/j.apsb.2021.03.008.","journal-title":"Acta Pharm Sin B"},{"key":"10262_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-021-02763-x","author":"LK Kadian","year":"2022","unstructured":"Kadian LK, Arora M, Prasad CP, Pramanik R, Chauhan SS. Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma. Clin Transl Oncol. 2022. https:\/\/doi.org\/10.1007\/s12094-021-02763-x.","journal-title":"Clin Transl Oncol"},{"key":"10262_CR5","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.21037\/tcr-24-198","volume":"13","author":"M Wang","year":"2024","unstructured":"Wang M, Dong W, Liu A et al. Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis. Transl Cancer Res. 2024;13:2735\u20132750. https:\/\/doi.org\/10.21037\/tcr-24-198.","journal-title":"Transl Cancer Res."},{"key":"10262_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/2045-3701-1-41","volume":"1","author":"G Han","year":"2011","unstructured":"Han G, Wang X-J. Roles of TGF\u03b2 signaling Smads in squamous cell carcinoma. Cell Biosci 2011;1:41. https:\/\/doi.org\/10.1186\/2045-3701-1-41.","journal-title":"Cell Biosci"},{"key":"10262_CR7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.tranon.2018.11.010","volume":"12","author":"J Luo","year":"2019","unstructured":"Luo J, Chen X-Q, Li P. The Role of TGF-\u03b2 and Its Receptors in Gastrointestinal Cancers. Transl Oncol 2019;12:475\u2013484. https:\/\/doi.org\/10.1016\/j.tranon.2018.11.010.","journal-title":"Transl Oncol"},{"key":"10262_CR8","doi-asserted-by":"publisher","first-page":"e18761429249717","DOI":"10.2174\/0118761429249717230920113227","volume":"17","author":"A Keshavarzmotamed","year":"2024","unstructured":"Keshavarzmotamed A, Mousavi V, Masihipour N et al. Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy. Curr Mol Pharmacol 2024;17:e18761429249717. https:\/\/doi.org\/10.2174\/0118761429249717230920113227.","journal-title":"Curr Mol Pharmacol"},{"key":"10262_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cancergen.2025.09.007","volume":"298\u2013299","author":"X Zhang","year":"2025","unstructured":"Zhang X, Xie J, Fu T et al. The multidimensional role of laminin \u03b32 (LAMC2) on cancer progression. Cancer Genet 2025;298\u2013299:122\u2013127. https:\/\/doi.org\/10.1016\/j.cancergen.2025.09.007.","journal-title":"Cancer Genet"},{"key":"10262_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biom10030487","author":"K Tzavlaki","year":"2020","unstructured":"Tzavlaki K, Moustakas A. TGF-\u03b2 Signaling. Biomolecules. 2020. https:\/\/doi.org\/10.3390\/biom10030487.","journal-title":"Biomolecules"},{"key":"10262_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/PAS.0000000000000356","volume":"39","author":"AD Singhi","year":"2015","unstructured":"Singhi AD, Foxwell TJ, Nason K et al. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival. Am J Surg Pathol 2015;39:487\u2013495. https:\/\/doi.org\/10.1097\/PAS.0000000000000356.","journal-title":"Am J Surg Pathol"},{"key":"10262_CR12","doi-asserted-by":"crossref","unstructured":"Wan R, Feng J, Tang L. Consequences of Mutations and Abnormal Expression of SMAD4 in Tumors and T Cells. Onco. Targets Theor. 14, 2531\u20132540 n.d.","DOI":"10.2147\/OTT.S297855"},{"key":"10262_CR13","unstructured":"Natsugoe S, Xiangming C, Matsumoto M. Smad4 and transforming growth factor \u03b21 expression in patients with squamous cell carcinoma of the esophagus. Clinical Cancer \u2026 2002."},{"key":"10262_CR14","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3892\/ol.2015.3146","volume":"9","author":"H Cheng","year":"2015","unstructured":"Cheng H, Chen C, Liu LU, Zhan NA, Li B. Expression of Smad4, TGF-\u03b2RII, and p21waf1 in esophageal squamous cell carcinoma tissue. Oncol Lett 2015;9:2847\u20132853. https:\/\/doi.org\/10.3892\/ol.2015.3146.","journal-title":"Oncol Lett"},{"key":"10262_CR15","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.ajpath.2012.02.006","volume":"180","author":"DF Vincent","year":"2012","unstructured":"Vincent DF, Gout J, Chuvin N et al. Tif1\u03b3 suppresses murine pancreatic tumoral transformation by a Smad4-independent pathway. Am J Pathol 2012;180:2214\u20132221. https:\/\/doi.org\/10.1016\/j.ajpath.2012.02.006.","journal-title":"Am J Pathol"},{"key":"10262_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12885-015-1471-y","volume":"15","author":"L Kassem","year":"2015","unstructured":"Kassem L, Deygas M, Fattet L et al. TIF1\u03b3 interferes with TGF\u03b21\/SMAD4 signaling to promote poor outcome in operable breast cancer patients. BMC Cancer 2015;15:453. https:\/\/doi.org\/10.1186\/s12885-015-1471-y.","journal-title":"BMC Cancer"},{"key":"10262_CR17","doi-asserted-by":"publisher","first-page":"153303382211145","DOI":"10.1177\/15330338221114505","volume":"21","author":"F Wang","year":"2022","unstructured":"Wang F, Wang W, Wu X et al. Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in Gastric Cancer. Technol Cancer Res Treat 2022;21:15330338221114504. https:\/\/doi.org\/10.1177\/15330338221114505.","journal-title":"Technol Cancer Res Treat"},{"key":"10262_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1515\/hsz-2023-0233","volume":"405","author":"Y Wu","year":"2024","unstructured":"Wu Y, Yu B, Ai X et al. TIF1\u03b3 and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis. Biol Chem 2024;405:241\u2013256. https:\/\/doi.org\/10.1515\/hsz-2023-0233.","journal-title":"Biol Chem"},{"key":"10262_CR19","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3748\/wjg.v17.i35.3994","volume":"17","author":"S Jain","year":"2011","unstructured":"Jain S, Singhal S, Francis F et al. Association of overexpression of TIF1\u03b3 with colorectal carcinogenesis and advanced colorectal adenocarcinoma. World J Gastroenterol 2011;17:3994\u20134000. https:\/\/doi.org\/10.3748\/wjg.v17.i35.3994.","journal-title":"World J Gastroenterol"},{"key":"10262_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/embor.2011.78","volume":"12","author":"C Hesling","year":"2011","unstructured":"Hesling C, Fattet L, Teyre G et al. Antagonistic regulation of EMT by TIF1\u03b3 and Smad4 in mammary epithelial cells. EMBO Rep 2011;12:665\u2013672. https:\/\/doi.org\/10.1038\/embor.2011.78.","journal-title":"EMBO Rep"},{"key":"10262_CR21","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1172\/JCI45213","volume":"121","author":"R Aucagne","year":"2011","unstructured":"Aucagne R, Droin N, Paggetti J et al. Transcription intermediary factor 1\u03b3 is a tumor suppressor in mouse and human chronic myelomonocytic leukemia. J Clin Invest 2011;121:2361\u20132370. https:\/\/doi.org\/10.1172\/JCI45213.","journal-title":"J Clin Invest"},{"key":"10262_CR22","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1007\/s12672-025-02966-6","volume":"16","author":"A Chaudhary","year":"2025","unstructured":"Chaudhary A, Kumar M, Mohan L et al. Promoter methylation correlates with reduced SMAD4 expression in patients with breast cancer. Discov Oncol 2025;16:1484. https:\/\/doi.org\/10.1007\/s12672-025-02966-6.","journal-title":"Discov Oncol"},{"key":"10262_CR23","unstructured":"Wei H, She HY, Liu WL et al. Methylation and mRNA expression of WWOX and smad4 gene in gastric cardia adenocarcinoma. Int J Clin Exp Med 2016."},{"key":"10262_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ab.2008.03.014","volume":"377","author":"K Hattermann","year":"2008","unstructured":"Hattermann K, Mehdorn HM, Mentlein R, Schultka S, Held-Feindt J. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis. Anal Biochem 2008;377:62\u201371. https:\/\/doi.org\/10.1016\/j.ab.2008.03.014.","journal-title":"Anal Biochem"},{"key":"10262_CR25","doi-asserted-by":"publisher","first-page":"CNS74","DOI":"10.2217\/cns-2021-0002","volume":"10","author":"N Nguyen","year":"2021","unstructured":"Nguyen N, Redfield J, Ballo M et al. Identifying the optimal cutoff point for MGMT promoter methylation status in glioblastoma. CNS Oncol. 2021;10:CNS74. https:\/\/doi.org\/10.2217\/cns-2021-0002.","journal-title":"CNS Oncol."},{"key":"10262_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"10262_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/ol.2012.967","volume":"5","author":"J Dimberg","year":"2013","unstructured":"Dimberg J, Hong TT, Skarstedt M, L\u00f6fgren S, Zar N, Matussek A. Analysis of APC and IGFBP7 promoter gene methylation in Swedish and Vietnamese colorectal cancer patients. Oncol Lett 2013;5:25\u201330. https:\/\/doi.org\/10.3892\/ol.2012.967.","journal-title":"Oncol Lett"},{"key":"10262_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11033-025-10390-w","volume":"52","author":"J Talukdar","year":"2025","unstructured":"Talukdar J, Kataki K, Choudhury BN et al. Downregulation of SMAD2 and SMAD4 is associated with poor prognosis and shorter survival in esophageal squamous cell carcinoma. Mol Biol Rep 2025;52:274. https:\/\/doi.org\/10.1007\/s11033-025-10390-w.","journal-title":"Mol Biol Rep"},{"key":"10262_CR29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2006.03.045","volume":"125","author":"W He","year":"2006","unstructured":"He W, Dorn DC, Erdjument-Bromage H. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 2006;125:929\u2013941. https:\/\/doi.org\/10.1016\/j.cell.2006.03.045.","journal-title":"Cell"},{"key":"10262_CR30","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.27273","volume":"60","author":"Z Ding","year":"2014","unstructured":"Ding Z, Jin G, Wang W et al. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Hepatology 2014;60:1620\u20131636. https:\/\/doi.org\/10.1002\/hep.27273.","journal-title":"Hepatology"},{"key":"10262_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050726","author":"S Suriyamurthy","year":"2019","unstructured":"Suriyamurthy S, Baker D, Ten Dijke P, Iyengar PV. Epigenetic Reprogramming of TGF-\u03b2 Signaling in Breast Cancer. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11050726.","journal-title":"Cancers (Basel)"},{"key":"10262_CR32","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3389\/fonc.2019.01535","volume":"9","author":"J-C Qi","year":"2019","unstructured":"Qi J-C, Yang Z, Zhang Y-P et al. miR-20b-5p, TGFBR2, and E2F1 Form a Regulatory Loop to Participate in Epithelial to Mesenchymal Transition in Prostate Cancer. Front Oncol 2019;9:1535. https:\/\/doi.org\/10.3389\/fonc.2019.01535.","journal-title":"Front Oncol"},{"key":"10262_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.cell.2011.11.032","volume":"147","author":"Q Xi","year":"2011","unstructured":"Xi Q, Wang Z, Zaromytidou A-I et al. A poised chromatin platform for TGF-\u03b2 access to master regulators. Cell 2011;147:1511\u20131524. https:\/\/doi.org\/10.1016\/j.cell.2011.11.032.","journal-title":"Cell"},{"key":"10262_CR34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41419-024-07137-z","volume":"15","author":"T Xia","year":"2024","unstructured":"Xia T, Meng L, Xu G, Sun H, Chen H. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. Cell Death Dis 2024;15:740. https:\/\/doi.org\/10.1038\/s41419-024-07137-z.","journal-title":"Cell Death Dis"},{"key":"10262_CR35","doi-asserted-by":"publisher","first-page":"6156","DOI":"10.1038\/ncomms7156","volume":"6","author":"J Xue","year":"2015","unstructured":"Xue J, Chen Y, Wu Y et al. Tumour suppressor TRIM33 targets nuclear \u03b2-catenin degradation. Nat Commun 2015;6:6156. https:\/\/doi.org\/10.1038\/ncomms7156.","journal-title":"Nat Commun"},{"key":"10262_CR36","doi-asserted-by":"publisher","first-page":"8409239","DOI":"10.1155\/2020\/8409239","volume":"2020","author":"Y Xu","year":"2020","unstructured":"Xu Y, Wu G, Zhang J et al. TRIM33 overexpression inhibits the progression of clear cell renal cell carcinoma in vivo and in vitro. Biomed Res Int 2020;2020:8409239. https:\/\/doi.org\/10.1155\/2020\/8409239.","journal-title":"Biomed Res Int"},{"key":"10262_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.cancergen.2025.07.014","volume":"296\u2013297","author":"W Dong","year":"2025","unstructured":"Dong W, Lau C-H, Li J et al. Pan-cancer methylation analysis of circulating cell-free DNA. Cancer Genet 2025;296\u2013297:182\u2013195. https:\/\/doi.org\/10.1016\/j.cancergen.2025.07.014.","journal-title":"Cancer Genet"},{"key":"10262_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17223720","author":"H Liu","year":"2025","unstructured":"Liu H, Karsidag I, Golin R, Wu G. Bridging discovery and treatment: cancer biomarker. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17223720.","journal-title":"Cancers (Basel)"},{"key":"10262_CR39","first-page":"597","volume":"17","author":"D Zhi-ming","year":"2010","unstructured":"Zhi-ming D, Wei GUO, Yan-li GUO. Methylation status of CpG island of Smad4 gene in esophageal squamous cell carcinoma. \u4e2d\u56fd\u80bf\u7624\u751f\u7269. 2010;17:597\u2013603.","journal-title":"\u4e2d\u56fd\u80bf\u7624\u751f\u7269."},{"key":"10262_CR40","first-page":"1549","volume":"6","author":"C Jing","year":"2016","unstructured":"Jing C, Ma G, Li X et al. MicroRNA-17\/20a impedes migration and invasion via TGF-\u03b2\/ITGB6 pathway in esophageal squamous cell carcinoma. Am J Cancer Res 2016;6:1549\u20131562.","journal-title":"Am J Cancer Res"},{"key":"10262_CR41","first-page":"2004","volume":"20","author":"L Li","year":"2016","unstructured":"Li L, Xu QH, Dong YH et al. MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells. Eur Rev Med Pharmacol Sci 2016;20:2004\u20132010.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10262_CR42","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/cam4.1981","volume":"8","author":"X Tian","year":"2019","unstructured":"Tian X, Fei Q, Du M et al. miR-130a-3p regulated TGF-\u03b21-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells. Cancer Med 2019;8:1197\u20131208. https:\/\/doi.org\/10.1002\/cam4.1981.","journal-title":"Cancer Med"},{"key":"10262_CR43","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2751602\/v1","author":"YG \u00dcr\u00fcn","year":"2023","unstructured":"\u00dcr\u00fcn YG, Budak M, Keskin EU. Methylation status, mRNA and protein expression of the SMAD4 gene in patients with non-melanocytic skin cancers. Res Sq. 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2751602\/v1.","journal-title":"Res Sq"},{"key":"10262_CR44","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12032-014-0102-9","volume":"31","author":"J Chao","year":"2014","unstructured":"Chao J, Zhang X-F, Pan Q-Z et al. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma. Med Oncol 2014;31:102. https:\/\/doi.org\/10.1007\/s12032-014-0102-9.","journal-title":"Med Oncol"},{"key":"10262_CR45","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.1007\/s11033-012-1810-x","volume":"39","author":"W Guo","year":"2012","unstructured":"Guo W, Dong Z, Guo Y et al. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma. Mol Biol Rep 2012;39:9453\u20139462. https:\/\/doi.org\/10.1007\/s11033-012-1810-x.","journal-title":"Mol Biol Rep"},{"key":"10262_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/mmr_00000064","volume":"2","author":"K Takenaka","year":"2009","unstructured":"Takenaka K, Gemma A, Yoshimura A et al. Reduced transcription of the Smad4 gene during pulmonary carcinogenesis in idiopathic pulmonary fibrosis. Mol Med Report 2009;2:73\u201380. https:\/\/doi.org\/10.3892\/mmr_00000064.","journal-title":"Mol Med Report"},{"key":"10262_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s43556-022-00109-9","volume":"3","author":"Y Tie","year":"2022","unstructured":"Tie Y, Tang F, Peng D, Zhang Y, Shi H. TGF-beta signal transduction: biology, function and therapy for diseases. Mol Biomed 2022;3:45. https:\/\/doi.org\/10.1186\/s43556-022-00109-9.","journal-title":"Mol Biomed"},{"key":"10262_CR48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fonc.2019.00979","volume":"9","author":"C Yu","year":"2019","unstructured":"Yu C, Ding Z, Liang H, Zhang B, Chen X. The roles of tif1\u03b3 in cancer. Front Oncol 2019;9:979. https:\/\/doi.org\/10.3389\/fonc.2019.00979.","journal-title":"Front Oncol"},{"key":"10262_CR49","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41388-018-0481-z","volume":"38","author":"R Yuki","year":"2019","unstructured":"Yuki R, Tatewaki T, Yamaguchi N et al. Desuppression of TGF-\u03b2 signaling via nuclear c-Abl-mediated phosphorylation of TIF1\u03b3\/TRIM33 at Tyr-524, -610, and -1048. Oncogene 2019;38:637\u2013655. https:\/\/doi.org\/10.1038\/s41388-018-0481-z.","journal-title":"Oncogene"},{"key":"10262_CR50","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/onc.2015.141","volume":"35","author":"L Wang","year":"2016","unstructured":"Wang L, Yang H, Lei Z et al. Repression of TIF1\u03b3 by SOX2 promotes TGF-\u03b2-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Oncogene 2016;35:867\u2013877. https:\/\/doi.org\/10.1038\/onc.2015.141.","journal-title":"Oncogene"},{"key":"10262_CR51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12032-010-9816-5","volume":"29","author":"J Lv","year":"2012","unstructured":"Lv J, Cao X-F, Ji L et al. Association of \u03b2-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma. Med Oncol 2012;29:151\u2013160. https:\/\/doi.org\/10.1007\/s12032-010-9816-5.","journal-title":"Med Oncol"},{"key":"10262_CR52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s13277-013-1088-1","volume":"35","author":"N Liu","year":"2014","unstructured":"Liu N, Xi Y, Callaghan MU et al. SMAD4 is a potential prognostic marker in human breast carcinomas. Tumour Biol 2014;35:641\u2013650. https:\/\/doi.org\/10.1007\/s13277-013-1088-1.","journal-title":"Tumour Biol"},{"key":"10262_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2407-6-25","volume":"6","author":"CH Stuelten","year":"2006","unstructured":"Stuelten CH, Buck MB, Dippon J et al. Smad4-expression is decreased in breast cancer tissues: a retrospective study. BMC Cancer 2006;6:25. https:\/\/doi.org\/10.1186\/1471-2407-6-25.","journal-title":"BMC Cancer"},{"key":"10262_CR54","doi-asserted-by":"publisher","unstructured":"Salovaara R, Roth S, Loukola A et al. Frequent loss of SMAD4\/DPC4 protein in colorectal cancers. Gut 2002;5:56\u201359. https:\/\/doi.org\/10.1136\/gut.51.1.56.","DOI":"10.1136\/gut.51.1.56"},{"key":"10262_CR55","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/cncr.10727","volume":"95","author":"M Fukuchi","year":"2002","unstructured":"Fukuchi M, Masuda N, Miyazaki T et al. Decreased Smad4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma. Cancer 2002;95:737\u2013743. https:\/\/doi.org\/10.1002\/cncr.10727.","journal-title":"Cancer"},{"key":"10262_CR56","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1245\/s10434-025-17238-4","volume":"32","author":"A Yamaguchi","year":"2025","unstructured":"Yamaguchi A, Yokobori T, Sohda M et al. Low TIF1\u03b3 Expression is Associated with Cancer Aggressiveness and Shorter Recurrence-Free Survival in Patients with Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2025;32:6023\u20136030. https:\/\/doi.org\/10.1245\/s10434-025-17238-4.","journal-title":"Ann Surg Oncol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10262-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10262-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:06:12Z","timestamp":1791313572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10262-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":56,"alternative-id":["10262"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10262-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial or personal interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}